The new European biotech act, announced in Ursula von der Leyen’s political guidelines for 2025, was not included in the Commission work programme published on 11 February, but has recently been announced for early 2026.
News & Trends
Procurar
Recentes
- A Formiventos está novamente no ranking das Top 5% melhores PME de Portugal
- Electronic Submission Template for Premarket Approval Applications (PMAs)
- MDSAP Technical Review and Recognition Decision Procedure
- Essential Principles and Content of Predetermined Change Control Plans. Final Document
- Report on the International Active Pharmaceutical Ingredient Inspection Programme 2017 – 2024
- GMP and GDP Question and Answer Guide Version 03 published by ECA
- Guideline on good pharmacovigilance practices (GVP) Module III – Pharmacovigilance inspections (Rev 2)
- Publication of COMBINE Project 2 Sponsors’ guide on safety reporting in combined studies